Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Heparin-induced thrombocytopenia].

F Depasse1, M M Samama

  • 1LCL Laboratoire Claude-Lévy, 78, avenue de Verdun, 94200 Ivry-sur-Seine.

Annales De Biologie Clinique
|June 10, 2000
PubMed
Summary

Heparin-induced thrombocytopenia (HIT) is a serious complication caused by antibodies targeting heparin and platelet factor 4. Diagnosis involves clinical and lab tests, with treatment including heparin cessation and alternative anticoagulants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clot waveform analysis: Where do we stand in 2017?

International journal of laboratory hematology·2017
Same author

The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis.

Hematology (Amsterdam, Netherlands)·2016
Same author

[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].

Annales francaises d'anesthesie et de reanimation·2013
Same author

[Hemorrhagic accidents of the new oral anticoagulants and coagulation assays].

Journal des maladies vasculaires·2013
Same author

Which test to use to measure the anticoagulant effect of rivaroxaban: the anti-factor Xa assay.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux.

Thrombosis and haemostasis·2011

Area of Science:

  • Hematology
  • Immunology
  • Pharmacology

Background:

  • Heparin-induced thrombocytopenia (HIT) is a life-threatening immune complication associated with heparin therapy.
  • The primary mechanism involves antibodies against the heparin-platelet factor 4 (PF4) complex.
  • These antibodies can trigger platelet activation and subsequent thromboembolic events.

Purpose of the Study:

  • To summarize the understanding of HIT's pathophysiology.
  • To outline diagnostic approaches for HIT.
  • To review current treatment strategies for HIT.

Main Methods:

  • Review of clinical features suggestive of HIT.
  • Description of diagnostic tests, including functional and immunological assays.
  • Discussion of therapeutic options for managing HIT.

Main Results:

  • Antibody formation against the heparin-PF4 complex is the key driver of HIT.
  • Clinical presentation and diagnostic tests aid in HIT identification.
  • Discontinuation of heparin and initiation of alternative anticoagulation are crucial.

Conclusions:

  • HIT is a significant risk of heparin use, driven by specific antibodies.
  • Accurate diagnosis relies on a combination of clinical suspicion and laboratory confirmation.
  • Effective management necessitates immediate heparin withdrawal and prompt alternative anticoagulant therapy, such as Orgaran or Refludan.

Related Experiment Videos